Volume 8; Issue 3

Nature Reviews Drug Discovery

Volume 8; Issue 3
1

Molecular targets for cancer chemoprevention

William, William N., Heymach, John V., Kim, Edward S., Lippman, Scott M.
Journal:
Nature Reviews Drug Discovery
Year:
2009
Language:
english
File:
PDF, 485 KB
english, 2009
2

Portfolio analysis and R&D decision making

Evans, Richard, Hinds, Scott, Hammock, Denise
Journal:
Nature Reviews Drug Discovery
Year:
2009
Language:
english
File:
PDF, 233 KB
english, 2009
3

The FGF family: biology, pathophysiology and therapy

Beenken, Andrew, Mohammadi, Moosa
Journal:
Nature Reviews Drug Discovery
Year:
2009
Language:
english
File:
PDF, 831 KB
english, 2009
5

Glycosylation as a strategy to improve antibody-based therapeutics

Jefferis, Roy
Journal:
Nature Reviews Drug Discovery
Year:
2009
Language:
english
File:
PDF, 454 KB
english, 2009
7

Febuxostat

Pascual, Eliseo, Sivera, Francisca, Yasothan, Uma, Kirkpatrick, Peter
Journal:
Nature Reviews Drug Discovery
Year:
2009
Language:
english
File:
PDF, 241 KB
english, 2009
8

Antibacterials: Vive la difference!

Hoyos Flight, Monica
Journal:
Nature Reviews Drug Discovery
Year:
2009
Language:
english
File:
PDF, 181 KB
english, 2009
9

Obesity: Reversing leptin resistance

Crunkhorn, Sarah
Journal:
Nature Reviews Drug Discovery
Year:
2009
Language:
english
File:
PDF, 203 KB
english, 2009
10

Neurodegenerative disease: Reversing defective lysosomal transport

Harrison, Charlotte
Journal:
Nature Reviews Drug Discovery
Year:
2009
Language:
english
File:
PDF, 184 KB
english, 2009
11

Anticancer drugs: Inhibiting hedgehog

Hughes, Bethan
Journal:
Nature Reviews Drug Discovery
Year:
2009
Language:
english
File:
PDF, 215 KB
english, 2009
12

Drug metabolism: Seeking the soft spots

Kirkpatrick, Peter
Journal:
Nature Reviews Drug Discovery
Year:
2009
Language:
english
File:
PDF, 142 KB
english, 2009
13

In Brief

Journal:
Nature Reviews Drug Discovery
Year:
2009
Language:
english
File:
PDF, 145 KB
english, 2009
14

Deal watch: Synta and Roche collaborate on anti-inflammatory ion channel modulators

Journal:
Nature Reviews Drug Discovery
Year:
2009
Language:
english
File:
PDF, 149 KB
english, 2009
15

Market watch: Specialty pharmaceuticals to provide majority of sales by 2012

Goodman, Michael
Journal:
Nature Reviews Drug Discovery
Year:
2009
Language:
english
File:
PDF, 127 KB
english, 2009
16

Deal watch: Anti-IL-5 antibody attracts Cephalon to agree option for Ception acquisition

Journal:
Nature Reviews Drug Discovery
Year:
2009
Language:
english
File:
PDF, 124 KB
english, 2009
17

Ruth McKernan

Journal:
Nature Reviews Drug Discovery
Year:
2009
Language:
english
File:
PDF, 153 KB
english, 2009
18

Regulatory Affairs

Journal:
Nature Reviews Drug Discovery
Year:
2009
Language:
english
File:
PDF, 161 KB
english, 2009
19

In this issue

Journal:
Nature Reviews Drug Discovery
Year:
2009
Language:
english
File:
PDF, 257 KB
english, 2009
20

Combating the cons of consolidation

Journal:
Nature Reviews Drug Discovery
Year:
2009
Language:
english
File:
PDF, 94 KB
english, 2009
21

Biomarker debate highlights retrospective challenge

Jones, Dan
Journal:
Nature Reviews Drug Discovery
Year:
2009
Language:
english
File:
PDF, 380 KB
english, 2009
22

Gearing up for follow-on biologics

Hughes, Bethan
Journal:
Nature Reviews Drug Discovery
Year:
2009
Language:
english
File:
PDF, 131 KB
english, 2009
23

In Brief

Journal:
Nature Reviews Drug Discovery
Year:
2009
Language:
english
File:
PDF, 677 KB
english, 2009
24

Patent watch

Harrison, Charlotte
Journal:
Nature Reviews Drug Discovery
Year:
2009
Language:
english
File:
PDF, 243 KB
english, 2009